Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • The Inquiry Report
    • Additional Compensation Report
    • First Interim Report
    • Second Interim Report
    • Compensation Framework Study
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • NHS Psychological Support
    • Confidential Psychological Support
    • Support Groups
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
  • Contact us
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

Subscribe to Search results

Kevin Slater was 20 years old when his AIDS symptoms were first identified and just 22 years old when he died in 1985.

Published on: 27 September, 2024

In his statement to the Haemophilia Society, Professor Bloom stated that he was "unaware of any proven case" of AIDS among people with haemophilia in the UK.

Published on: 27 September, 2024

The Communicable Disease Surveillance Centre ("CDSC") published a weekly report observing Kevin Slater's case as"This is the first report of AIDS in a patient with haemophilia in the United Kingdom known to CDSC."

Published on: 27 September, 2024

Dr Nicol Spence Galbraith (CDSC), notified the DHSS regarding the report of AIDS in a patient with haemophilia in the United Kingdom.

Published on: 27 September, 2024

Dr Galbraith (PHLS) concluded in a letter to Dr Ian Field (DHSS) that all products made from blood donated in the USA after 1978 should be withdrawn from use.

Published on: 27 September, 2024

Dr Walford, wrote a memo to Dr Field regarding Dr Galbraith's conclusion on the withdrawal of all blood products from donated blood in the USA.

Published on: 27 September, 2024

Professor Bloom stated in a letter to the haemophilia centres directors "I hope that it will be possible rapidly to vary the Product Licence for relevant imported products to take account of these recent developments."

Published on: 27 September, 2024

The Council of Europe issued its recommendations which included avoiding, the use of coagulation factor concentrates prepared from large plasma pools and informing people with haemophilia of the potential health hazards of haemotherapy and the possibilities of minimising these risks.

Published on: 27 September, 2024

At the Hepatitis Working Party's meeting the position in relation to the occurence of cases of AIDS in haemophilia A patients treated with commercial factor concentrates was reviewed. It was stated that there had been two cases of the syndrome in the UK.

Published on: 27 September, 2024

Dr Delamore stated that he appreciated that the freeze-dried preparations were much more suitable for home treatment, which he now hoped to institute in selected cases.

Published on: 27 September, 2024

Except for two patients on a period of prophylaxis with commercial concentrate noted below, all 10 other severe haemophiliac participants were treated with NHS freeze-dried factor-VIII concentrate prepared by the Lister Institute Laboratories.

Published on: 27 September, 2024

Inquiry publishes financial annual report

Published on: 08 September, 2022

The 1977 annual return from the Oxford Haemophilia Centre recorded no use of cryoprecipitate at all and greater use of commercial concentrates than NHS.

Published on: 27 September, 2024

In 1979, return records show no cryoprecipitate; a small amount of Elstree Factor 8; 1,078,110 units of Oxford Factor 8; and 906,830 units of commercial (Factorate, Koate, Hemofil).

Published on: 27 September, 2024

The Belfast Haemophilia Centre, based at Royal Victoria Hospital (RVI), was designated as a reference centre.

Published on: 27 September, 2024

Paul Winstanley wrote a note on the imports of blood products into the United Kingdom for medical purposes to Dr Walford and Mrs Walden.

Published on: 27 September, 2024

A paper was presented by Dr Craske at the meeting of the UK Haemophilia Reference Centre Directors, updating the situation regarding AIDS. It was agreed that the patients who had received the same batches of NHS or commercial Factor 8 as the patient who died in Bristol should be followed up.

Published on: 30 September, 2024

A paper on AIDS Investigation was prepared by Dr Craske for the UK Haemophilia Centre Directors.

Published on: 30 September, 2024

Dr Craske presented this 'Appendix B Surveillance of AIDS cases in patients with blood coagulation disorders' paper which had been pre-circulated to directors.

Published on: 30 September, 2024

The President of the British Society for Haematology decided that a Working Party should be formed "to investigate the problem of Aids in relation to the practice of Haematology in the Diagnostic Laboratory."

Published on: 30 September, 2024

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 2327
  • Page 2328
  • Page 2329
  • Page 2330
  • Current page 2331
  • Page 2332
  • Page 2333
  • Page 2334
  • Page 2335
  • …
  • Next page Next
  • Last page Last

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.